132
11. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth:
United States, 2011-2014. NCHS Data Brief. 2015;219:1–8.
12. Herman KM, Craig CL, Gauvin L, Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: the physical activity longitudinal study. Int J Pediatr Obes.
2009;4(4):281–8.
13. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ, Trasande L. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European
Union. J Clin Endocrinol Metab. 2015;100(4):1278–88.
14. Federation Id. Epidemiology and research. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/159-idf-diabetes-atlas-ninth-edition-2019.html.
15. Gedela V, Gosala SL. Diabetes a risk for antimicrobial resistance? Int J Basic Clin Pharmacol.
2017;6(12):4.
16. Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US
adult population: findings from the National Health and Nutrition Examination Survey, 19992006. Obes Surg. 2011;21(3):351–5.
17. Carroll M, Kit B, Lacher D. Trends in elevated triglyceride in adults: United States, 20012012. NCHS Data Brief. 2015;198:198.
18. van Hoek AH, Mevius D, Guerra B, Mullany P, Roberts AP, Aarts HJ. Acquired antibiotic
resistance genes: an overview. Front Microbiol. 2011;2:203.
19. Bax R, Griffin D. Introduction to antibiotic resistance. In: ARM C, editor. Antibiotic resistance. Berlin, Heidelberg: Springer; 2012. p. 1–12.
20. MacGowan A, Macnaughton E. Antibiotic resistance. Medicine. 2017;45(10):622–8.
21. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369–78.
22. Whyte P, Fanning S, O’Brien S, O’Grady L, Solomon K. Tracing pathogens in red meat and
game production chains and at the abattoir. In: Brul S, Fratamico PM, TA MM, editors. Tracing
Pathogens in the Food Chain. Sawston: Woodhead Publishing; 2011. p. 393–432.
23. Tanna S, Lawson G. Application of bioanalytical methods to assess medication adherence in
clinical settings. In: Tanna S, Lawson G, editors. Analytical chemistry for assessing medication adherence. San Diego: Elsevier; 2016. p. 87–127.
24. Epstein S. Multidrug-resistant infections. In: Silverstein DC, Hopper K, editors. Small animal
critical care medicine. 2nd ed. St. Louis: W.B. Saunders; 2015. p. 537–40.
25. Bax R. Antibiotic resistance—a view from the pharmaceutical industry. In: van der Goot H,
editor. Pharmacochemistry library. Amsterdam: Elsevier; 1998. p. 237–41.
26. Valdés-Ramos R, Guadarrama-López AL, Martínez-Carrillo BE, Harbige LS. n-3 polyunsaturated fatty acids in type 2 diabetes mellitus. In: Watson RR, Preedy VR, editors. Bioactive food
as dietary interventions for diabetes. 2nd ed. Amsterdam: Academic Press; 2019. p. 193–209.
27. Boyanova L, Mitov I. Antibiotic resistance rates in causative agents of infections in diabetic
patients: rising concerns. Expert Rev Anti-Infect Ther. 2013;11(4):411–20.
28. Chakraborty A, Shenoy S, Adhikari P, Saralaya V, Rao S. Is diabetes mellitus an important
risk factor for the antibiotic resistance in extraintestinal pathogenic Escherichia coli? Indian J
Pathol Microbiol. 2017;60(4):546–9.
29. Lebowitz D, Gariani K, Kressmann B, Ev D, Huttner B, Bartolone P, Lê N, Mohamad M,
Lipsky BA, Uçkay I. Are antibiotic-resistant pathogens more common in subsequent episodes
of diabetic foot infection? Int J Infect Dis. 2017;59:61–4.
30. Andrade MJ, Jayaprakash C, Bhat S, Evangelatos N, Brand A, Satyamoorthy K. Antibioticsinduced obesity: a mitochondrial perspective. Pub Health Gen. 2017;20(5):257–73.
31. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol.
2015;11(3):182–90.
32. Borengasser SJ, Faske J, Kang P, Blackburn ML, Badger TM, Shankar K. In utero exposure to
prepregnancy maternal obesity and postweaning high-fat diet impair regulators of mitochondrial dynamics in rat placenta and offspring. Physiol Gen. 2014;46(23):841–50.
33. Zorzano A, Liesa M, Palacin M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol. 2009;41(10):1846–54.
H. Sharif et al.
11. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth:
United States, 2011-2014. NCHS Data Brief. 2015;219:1–8.
12. Herman KM, Craig CL, Gauvin L, Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: the physical activity longitudinal study. Int J Pediatr Obes.
2009;4(4):281–8.
13. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ, Trasande L. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European
Union. J Clin Endocrinol Metab. 2015;100(4):1278–88.
14. Federation Id. Epidemiology and research. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/159-idf-diabetes-atlas-ninth-edition-2019.html.
15. Gedela V, Gosala SL. Diabetes a risk for antimicrobial resistance? Int J Basic Clin Pharmacol.
2017;6(12):4.
16. Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US
adult population: findings from the National Health and Nutrition Examination Survey, 19992006. Obes Surg. 2011;21(3):351–5.
17. Carroll M, Kit B, Lacher D. Trends in elevated triglyceride in adults: United States, 20012012. NCHS Data Brief. 2015;198:198.
18. van Hoek AH, Mevius D, Guerra B, Mullany P, Roberts AP, Aarts HJ. Acquired antibiotic
resistance genes: an overview. Front Microbiol. 2011;2:203.
19. Bax R, Griffin D. Introduction to antibiotic resistance. In: ARM C, editor. Antibiotic resistance. Berlin, Heidelberg: Springer; 2012. p. 1–12.
20. MacGowan A, Macnaughton E. Antibiotic resistance. Medicine. 2017;45(10):622–8.
21. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369–78.
22. Whyte P, Fanning S, O’Brien S, O’Grady L, Solomon K. Tracing pathogens in red meat and
game production chains and at the abattoir. In: Brul S, Fratamico PM, TA MM, editors. Tracing
Pathogens in the Food Chain. Sawston: Woodhead Publishing; 2011. p. 393–432.
23. Tanna S, Lawson G. Application of bioanalytical methods to assess medication adherence in
clinical settings. In: Tanna S, Lawson G, editors. Analytical chemistry for assessing medication adherence. San Diego: Elsevier; 2016. p. 87–127.
24. Epstein S. Multidrug-resistant infections. In: Silverstein DC, Hopper K, editors. Small animal
critical care medicine. 2nd ed. St. Louis: W.B. Saunders; 2015. p. 537–40.
25. Bax R. Antibiotic resistance—a view from the pharmaceutical industry. In: van der Goot H,
editor. Pharmacochemistry library. Amsterdam: Elsevier; 1998. p. 237–41.
26. Valdés-Ramos R, Guadarrama-López AL, Martínez-Carrillo BE, Harbige LS. n-3 polyunsaturated fatty acids in type 2 diabetes mellitus. In: Watson RR, Preedy VR, editors. Bioactive food
as dietary interventions for diabetes. 2nd ed. Amsterdam: Academic Press; 2019. p. 193–209.
27. Boyanova L, Mitov I. Antibiotic resistance rates in causative agents of infections in diabetic
patients: rising concerns. Expert Rev Anti-Infect Ther. 2013;11(4):411–20.
28. Chakraborty A, Shenoy S, Adhikari P, Saralaya V, Rao S. Is diabetes mellitus an important
risk factor for the antibiotic resistance in extraintestinal pathogenic Escherichia coli? Indian J
Pathol Microbiol. 2017;60(4):546–9.
29. Lebowitz D, Gariani K, Kressmann B, Ev D, Huttner B, Bartolone P, Lê N, Mohamad M,
Lipsky BA, Uçkay I. Are antibiotic-resistant pathogens more common in subsequent episodes
of diabetic foot infection? Int J Infect Dis. 2017;59:61–4.
30. Andrade MJ, Jayaprakash C, Bhat S, Evangelatos N, Brand A, Satyamoorthy K. Antibioticsinduced obesity: a mitochondrial perspective. Pub Health Gen. 2017;20(5):257–73.
31. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol.
2015;11(3):182–90.
32. Borengasser SJ, Faske J, Kang P, Blackburn ML, Badger TM, Shankar K. In utero exposure to
prepregnancy maternal obesity and postweaning high-fat diet impair regulators of mitochondrial dynamics in rat placenta and offspring. Physiol Gen. 2014;46(23):841–50.
33. Zorzano A, Liesa M, Palacin M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol. 2009;41(10):1846–54.
H. Sharif et al.